SCHEMBL232776

SCHEMBL232776

CC#CC(c1ccc(NC(=O)C(C)Oc2cccc(C(C)(C)C)c2)cc1)C(C(=O)OC)C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.49
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
RXFP1 Q9HBX9 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
STAT1 P42224 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL231684 0.91 FFAR1 (0.52) FFAR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL3132553 0.86 FFAR1 (0.54) FFAR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL232545 0.81 FFAR1 (0.70) FFAR1TSHR
SCHEMBL15468351 0.79 FFAR1 (0.57) FFAR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL10065062 0.76 FFAR1 (0.62) FFAR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL2753758 0.75 FFAR1 (0.59) FFAR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL2753691 0.72 FFAR1 (0.58) FFAR1
SCHEMBL10065682 0.70 FFAR1 (0.68) FFAR1
SCHEMBL231688 0.67 FFAR1 (0.54) FFAR1TSHRHTT
SCHEMBL2751966 0.67 FFAR1 (0.54) FFAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648038-B2 (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments SANOFI (FR) 2014-02-11 US disclosed
US-8648038-B2 (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments SANOFI (FR) 2014-02-11 US disclosed
US-20120004167-A1 (2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS SANOFI (FR) 2012-01-05 US disclosed
US-20120004167-A1 (2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS SANOFI (FR) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004167-A1 (2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS GPR119, DPP9, DPP7 FFAR1 96/4885ALDH1A1 91/4885TSHR 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.